Olympus Surgical Technologies Europe takes over Olympus Surgical UK
4 April 2011
Hamburg-based Olympus Surgical Technologies Europe has taken
over Olympus Surgical UK, the fifth company to join the expanding
corporate network.
A total of 1,100 employees with external sales of 450 million
euros are now working in three countries for the corporate network.
“The umbrella brand of Olympus Surgical, which was created one
year ago, is very successful,” says Heinz Jacqui, Managing Director
of Olympus Surgical Technologies Europe. “Our responsibility for
promising areas such as electrosurgery strengthens the position of
our company but also that of Germany as a location for medical
technology on the international market.”
The new addition of Olympus Surgical UK has become well-known
through its ‘see and treat’ solutions in the field of minimally
invasive surgery. In this pioneering role, Olympus Surgical UK
supplies a product platform for diagnostics and therapy and during
the actual treatment relies on a technique known as PK technology,
an electrosurgical procedure in which the wound created is sealed
again instantly in the same process step. The Welsh company
employees 250 people.
“Olympus Surgical UK is a significant gain for our group of
companies,“ says Heinz Jacqui. “Electrosurgery is one of the most
successful fields of application in medical technology because the
operations performed with such techniques are gentler on the patient
and help to save costs due to the fewer complications. Olympus
Surgical UK perfectly complements our existing range of products and
services and makes us a global pioneer in this promising field for
the future.“
A total of 1,100 people are employed at the locations of
Hamburg, Teltow near Berlin and Tuttlingen in Germany as well as
Přerov in the Czech Republic and Cardiff in Wales.
Olympus Surgical Technologies Europe was founded by Olympus on 1
April 2010 as a network of specialists in minimally invasive
diagnostics and therapy. Olympus Surgical is focusing on the
formation of a European Group of companies in order to ensure its
ongoing future growth and to extend its position in the field of
minimally invasive diagnostics and therapy.